Press Releases (Page 4)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Doximity, Global Cord, and Lincoln Innovations and Encourages Investors to Contact the Firm
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), Doximity, Inc. (NYSE: DOCS), Global Cord Blood Corporation (OTC: CORBF), and Lincoln National Corporation (NYSE: LNC). Stockholders have until the deadlines below to petition the... ❯❯❯
PRIMERICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Primerica Inc. on Behalf of Primerica Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Primerica Inc. (“Primerica” or the “Company”) (NYSE: PRI) on behalf of Primerica stockholders. Our investigation concerns whether Primerica has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Checkpoint, Sonder, Perion, and Autodesk and Encourages Investors to Contact the Firm
NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), Sonder Holdings Inc. (NASDAQ: SOND), Perion Network Ltd. (NASDAQ: PERI), and Autodesk, Inc. (NASDAQ: ADSK). Stockholders have until the deadlines below to petition the court to... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm
NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ocugen, Inc. (NASDAQ: OCGN), QuidelOrtho Corporation (NASDAQ: QDEL), Sharecare, Inc. (NASDAQ: SHCR), and GoodRx Holdings, Inc. (NASDAQ: GDRX). Stockholders have until the deadlines below to petition the court to serve as... ❯❯❯
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Talis Biomedical Corporation Talis Biomedical Corporation (NASDAQ: TLIS), TaskUs, Inc. (NASDAQ: TASK), and Rent the Runway, Inc. (NASDAQ: RENT) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. ... ❯❯❯
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Caribou Biosciences, Inc. (NASDAQ: CRBU), Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA), and Playstudios, Inc. (NASDAQ: MYPS) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Caribou Biosciences,... ❯❯❯
COMPASS MINERALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Compass Minerals International, Inc. and Encourages Investors to Contact the Firm
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Compass Minerals International, Inc. (“Compass Minerals” or the “Company”) (NYSE: CMP) in the United States District Court for the District of Kansas on behalf of all persons and entities who purchased or otherwise acquired Compass Minerals... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, and Rivian and Encourages Investors to Contact the Firm
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AST SpaceMobile, Inc. (NASDAQ: ASTS), and Rivian Automotive, Inc. (NASDAQ: RIVN). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, and Doximity Innovations and Encourages Investors to Contact the Firm
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), and Doximity, Inc. (NYSE: DOCS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found... ❯❯❯
CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cidara Therapeutics, Inc. (“Cidara Therapeutics” or the “Company”) (NASDAQ: CDTX) on behalf of Cidara Therapeutics stockholders. Our investigation concerns whether Cidara Therapeutics has violated the federal securities laws and/or engaged in other unlawful business... ❯❯❯
